• Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Get Email Updates
  • We’re hiring!
  • Focus Areas
    • Cause Selection
    • Global Health & Wellbeing
      • Farm Animal Welfare
      • Global Aid Policy
      • Global Health & Development
      • Scientific Research
      • South Asian Air Quality
    • Longtermism
      • Biosecurity & Pandemic Preparedness
      • Effective Altruism Community Growth
      • Potential Risks from Advanced AI
    • Other Areas
      • Criminal Justice Reform
      • History of Philanthropy
      • Immigration Policy
      • Land Use Reform
      • Macroeconomic Stabilization Policy
  • Grants
  • Research & Updates
    • Research Reports
    • Blog Posts
    • Notable Lessons
    • In the News
  • About Us
    • Grantmaking Process
    • How to Apply for Funding
    • Team
    • Get Email Updates
  • We’re hiring!

OliLux Biosciences — Rapid Tuberculosis Detection and Treatment Management Tools

Visit Grantee Site
  • Portfolio Area: Human Health and Wellbeing
  • Focus Area: Scientific Research
  • Organization Name: OliLux Biosciences
  • Amount: $400,000

  • Award Date: January 2021

Table of Contents


    Grant investigators: Heather Youngs and Chris Somerville

    This page was reviewed but not written by the grant investigators. OliLux Biosciences staff also reviewed this page prior to publication.


    Open Philanthropy recommended an investment of $400,000 in OliLux Biosciences to support the development of diagnostic and treatment monitoring tools for the detection and management of tuberculosis. The tools rapidly distinguish between active and inactive tuberculosis pathogens, have lower detection limits than existing detection methods, will be accessible in low-resource settings, and are expected to be useful in identification of drug resistance and sensitivity.

    This falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing.

    Related Items

    • Human Health and Wellbeing

      Ifakara Health Institute — Malaria Vaccine Clinical Trial (Ally Olotu)

      Open Philanthropy recommended a grant of $68,184 over three years to the Ifakara Health Institute to participate in a phase III clinical trial of a malaria vaccine developed...

      Read more
    • Human Health and Wellbeing

      Yale University — Malaria Vaccine Research (Richard Bucala)

      Grant Investigators: Chris Somerville and Heather Youngs This page was reviewed but not written by the grant investigators. Yale University staff also reviewed this page prior to publication. Open Philanthropy...

      Read more
    • Human Health and Wellbeing

      Kansas State University — Fungal Genetics Stock Center

      Open Philanthropy recommended a grant of $50,000 to Kansas State University to support the Fungal Genetics Stock Center. This funding is intended to support research on the biological...

      Read more
    Back to Grants Database
    Open Philanthropy
    Open Philanthropy
    • Careers
    • Press Kit
    • Governance
    • Privacy Policy
    Mailing Address
    182 Howard Street #225
    San Francisco, CA 94105
    Email
    [email protected]
    Media Inquiries
    [email protected]
    Anonymous Feedback
    Feedback Form

    Sign Up to Follow Our Work

    Join Our Mailing List

    © Open Philanthropy 2022